Lv6
1848 积分 2023-01-24 加入
CXCL12+ Tumor-associated Endothelial Cells Promote Immune Resistance in Hepatocellular Carcinoma
16天前
已完结
cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation
23天前
已完结
Alarmin-loaded extracellular lipid droplets induce airway neutrophil infiltration during type 2 inflammation
1个月前
已完结
Metformin synergizes with PD-1 blockade to promote normalization of tumor vessels via CD8T cells and IFNγ
1个月前
已完结
Molecular subtype identification and prognosis stratification by a immunogenic cell death-related gene expression signature in colorectal cancer
2个月前
已完结
Safety and efficacy of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors in a phase I dose escalation study
2个月前
已完结
Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects
2个月前
已完结
Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial
2个月前
已完结
Ivonescimab: First Approval
2个月前
已完结
Mechanism of action of ivonescimab (AK112/SMT112): a first-in-class tetravalent Fc-silent bispecific antibody with dual blockade of PD-1 and VEGF that promotes cooperative biological effects
2个月前
已完结
皖公网安备34019202002308
